Avantor Total Non-Operating Income/Expense 2018-2025 | AVTR
Avantor annual/quarterly total non-operating income/expense history and growth rate from 2018 to 2025. Total non-operating income/expense can be defined as the sum of all non-operating expenses for the given industry.
- Avantor total non-operating income/expense for the quarter ending March 31, 2025 was $-0.062B, a 6.09% decline year-over-year.
- Avantor total non-operating income/expense for the twelve months ending March 31, 2025 was $-0.227B, a 17.85% decline year-over-year.
- Avantor annual total non-operating income/expense for 2024 was $-0.231B, a 19.24% decline from 2023.
- Avantor annual total non-operating income/expense for 2023 was $-0.286B, a 2.44% increase from 2022.
- Avantor annual total non-operating income/expense for 2022 was $-0.279B, a 27.33% increase from 2021.
| Avantor Annual Total Non-Operating Income/Expense (Millions of US $) |
|
|---|---|
| 2024 | $-231 |
| 2023 | $-286 |
| 2022 | $-279 |
| 2021 | $-219 |
| 2020 | $-645 |
| 2019 | $-511 |
| 2018 | $-527 |
| 2017 | $-250 |
| Avantor Quarterly Total Non-Operating Income/Expense (Millions of US $) |
|
|---|---|
| 2025-03-31 | $-62 |
| 2024-12-31 | $-54 |
| 2024-09-30 | $-50 |
| 2024-06-30 | $-61 |
| 2024-03-31 | $-66 |
| 2023-12-31 | $-64 |
| 2023-09-30 | $-74 |
| 2023-06-30 | $-73 |
| 2023-03-31 | $-75 |
| 2022-12-31 | $-77 |
| 2022-09-30 | $-68 |
| 2022-06-30 | $-69 |
| 2022-03-31 | $-65 |
| 2021-12-31 | $-74 |
| 2021-09-30 | $-51 |
| 2021-06-30 | $-40 |
| 2021-03-31 | $-55 |
| 2020-12-31 | $-178 |
| 2020-09-30 | $-285 |
| 2020-06-30 | $-88 |
| 2020-03-31 | $-94 |
| 2019-12-31 | $-102 |
| 2019-09-30 | $-106 |
| 2019-06-30 | $-170 |
| 2019-03-31 | $-134 |
| 2018-12-31 | |
| 2018-09-30 | $-131 |
| 2018-06-30 | $-118 |
| 2017-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $8.770B | $6.784B |
| Avantor Inc. is a provider of critical products and services primarily to biopharma, healthcare, education & government, advanced technologies & applied materials industries. Avantor Inc. is based in Radnor, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $142.454B | 26.72 |
| Elevance Health (ELV) | United States | $92.629B | 11.95 |
| CVS Health (CVS) | United States | $85.338B | 10.61 |
| Cencora (COR) | United States | $56.647B | 20.56 |
| Natera (NTRA) | United States | $21.178B | 0.00 |
| DiDi Global (DIDIY) | China | $19.767B | 30.00 |
| BioMerieux (BMXMF) | France | $15.407B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.351B | 0.00 |
| Solventum (SOLV) | United States | $11.698B | 10.91 |
| CochLear (CHEOY) | Australia | $11.662B | 0.00 |
| ICON (ICLR) | Ireland | $11.545B | 10.73 |
| Revvity (RVTY) | United States | $11.293B | 19.07 |
| Doximity (DOCS) | United States | $11.076B | 57.60 |
| Viatris (VTRS) | United States | $10.258B | 3.26 |
| Medpace Holdings (MEDP) | United States | $8.769B | 23.29 |
| Sonic Healthcare (SKHHY) | Australia | $8.097B | 0.00 |
| HealthEquity (HQY) | United States | $7.835B | 38.54 |
| Charles River Laboratories (CRL) | United States | $5.818B | 11.48 |
| Amplifon S.p.A (AMFPF) | Italy | $4.285B | 22.62 |
| Bausch + Lomb (BLCO) | Canada | $4.064B | 23.96 |
| BrightSpring Health Services (BTSG) | United States | $3.654B | 33.66 |
| Sotera Health (SHC) | United States | $3.514B | 19.97 |
| Alignment Healthcare (ALHC) | United States | $3.073B | 0.00 |
| Surgery Partners (SGRY) | United States | $2.959B | 33.94 |
| Concentras Parent (CON) | United States | $2.792B | 14.52 |
| Organon (OGN) | United States | $2.493B | 2.65 |
| Progyny (PGNY) | United States | $1.990B | 43.83 |
| GeneDx Holdings (WGS) | United States | $1.887B | 73.88 |
| Ardent Health Partners (ARDT) | United States | $1.880B | 0.00 |
| Premier (PINC) | United States | $1.868B | 11.97 |
| GoodRx Holdings (GDRX) | United States | $1.795B | 39.00 |
| Agilon Health (AGL) | United States | $1.718B | 0.00 |
| PACS (PACS) | United States | $1.535B | 0.00 |
| Teladoc Health (TDOC) | United States | $1.239B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.110B | 9.31 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.039B | 0.00 |
| Establishment Labs Holdings (ESTA) | $0.963B | 0.00 | |
| CareDx (CDNA) | United States | $0.835B | 13.04 |
| AMN Healthcare Services Inc (AMN) | United States | $0.811B | 6.42 |
| Embecta (EMBC) | United States | $0.740B | 5.07 |
| Nutex Health (NUTX) | United States | $0.634B | 12.42 |
| QDM (QDMI) | Hong Kong, SAR China | $0.583B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.512B | 13.57 |
| Sonida Senior Living (SNDA) | United States | $0.454B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.426B | 0.00 |
| Enhabit (EHAB) | United States | $0.408B | 38.33 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.389B | 0.00 |
| SBC Medicals (SBC) | United States | $0.321B | 0.00 |
| LifeMD (LFMD) | United States | $0.319B | 0.00 |
| DocGo (DCGO) | United States | $0.236B | 9.62 |
| Oncology Institute (TOI) | United States | $0.212B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.196B | 0.00 |
| Beauty Health (SKIN) | United States | $0.143B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.110B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.090B | 0.00 |
| OncoCyte (OCX) | United States | $0.087B | 0.00 |
| So-Young (SY) | China | $0.085B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.077B | 0.00 |
| Biodesix (BDSX) | United States | $0.076B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.065B | 0.00 |
| NeueHealth (NEUE) | United States | $0.060B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.030B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.027B | 0.00 |
| ModivCare (MODV) | United States | $0.021B | 7.30 |
| KindlyMD (KDLY) | United States | $0.013B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.013B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.012B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.009B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| XWELL (XWEL) | United States | $0.004B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |